Adverse Events in an Intensive Care UNIT
DOI:
https://doi.org/10.21727/rpu.v16i1.4980Abstract
Introduction: The aim of this study was to find out about the most frequent Adverse Events (AEs) in patients admitted to a COVID-19 Intensive Care Unit (ICU) and to describe their clinical and epidemiological profile. Materials and methods: Cross-sectional study, carried out based on the analysis of medical records of patients admitted to a COVID-19 ICU of a public hospital in the interior of Bahia, in 2020. Results: The sample comprised 203 medical records, the majority of which were elderly (61.1%) and women (50.7%). 92.1% of those investigated had some comorbidity, the most frequent being systemic arterial hypertension - SAH (69.5%), type II diabetes mellitus - DM II (43.8%), obesity (28.1%) and smoking (21.7%). As for the occurrence of AEs, 56.6% of patients had suffered some incident. Of these, the most common were pressure injuries (LPPs) (23.6%), healthcare-associated infections (HAIs) (22.7%) and ventilator-associated pneumonias (VAPs) (13.8%). Among the AEs related to procedures, late tracheostomy (LQT) was the most common (14.3%). With regard to the outcome of the sample, there was a close ratio between deaths and discharges, 48.3% and 44.3% respectively. A large percentage (44.3%) stayed less than 7 days in the ICU and between 7 and 14 days in hospital (34.5%). Final considerations: AEs had a significant occurrence, with higher frequencies of LPPs, IRAS and PAVs. The study should be continued in order to investigate the possible association between the occurrence of AEs and the increased risk of death and longer hospital stay.
Keywords: Adverse Events; Intensive Care Units; COVID-19.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Roberta Barros de Miranda, Jocinei Ferreira Constâncio, Tatiane Oliveira de Souza Constâncio, Washington da Silva Santos, Jarlan Santana de Souza, Érika Souza Cardoso

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which allows sharing the work with acknowledgement of authorship and initial publication through this journal.
This license lets others distribute, remix, adapt and create upon your work, even commercially, as long as they credit you for the original creation. It is the most flexible license of all available. It is recommended for maximizing the dissemination and use of the licensed materials.
Authors are permitted to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. by posting it to an institutional repository or as a chapter in a book), with acknowledgement of the work's authorship and initial publication in this journal.
See the full legal text of the license at: https://creativecommons.org/licenses/by/4.0/









